Minimum requirements of biologic products
Material type:
TextPublication details: Japan: Ministry of Health and Welfare, 1956Description: 534 p. ; 22cmSubject(s):
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
| Open Shelf | NIH Library NIH Library | QV350 min 1956 (Browse shelf(Opens below)) | 1 | Available | BK00006093 | ||
| Open Shelf | NIH Library NIH Library | QV350 min 1956 (Browse shelf(Opens below)) | 2 | Available | BK00008441 |
Browsing NIH Library shelves, Shelving location: NIH Library Close shelf browser (Hides shelf browser)
| No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
| QV350 led 1951 A Review of the clinical uses of aureomycin | QV350 led 1951 A Review of the clinical uses of aureomycin | QV350 led 1952 The Fifth year of aureomycin | QV350 min 1956 Minimum requirements of biologic products | QV350 min 1956 Minimum requirements of biologic products | QV350 mod 1971 Mode of action | QV350 mus 1956 Terramycin (oxytetracycline) |
Acc. No. 00234 : 01002
There are no comments on this title.
Log in to your account to post a comment.